Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

NCT03048279 | Active Not Recruiting

• 2 other identifiers: RCR01-485NCI-2021-12213
• Study Type: observational
• Target: 1,500
• Locations: 1 country
• Sites: 1

Brief Summary

Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.

Conditions

Multiple Endocrine Neoplasia Syndromes

Keywords

Multiple Endocrine Neoplasia Syndromes; MEN1; MEN2; Relatives; Database; Questionnaires; Surveys

Outcome Measures

Primary Outcomes (1)

• Contribution of New and Prospective Data to Existing Database Library for Patients with MEN1 and MEN2 by Completion of Health Questionnaires

  25 years

Study Arms (2)

Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

Consented individuals will be interviewed by phone and/or mail to obtain medical history specific to their diagnosis of either MEN1 or MEN2.

Behavioral: Questionnaires

Close Relatives of Registered MDACC MEN Patients

Participants will be asked to complete a health and family history questionnaire. This questionnaire process may be completed by phone or mail.

Behavioral: Questionnaires

Interventions

Questionnaires BEHAVIORAL

Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2 Group: Participants interviewed by phone and/or mail to obtain medical history specific to their diagnosis of either MEN1 or MEN2. Close Relatives of Registered MDACC MEN Patients Group: Participants asked to complete a health and family history questionnaire. This questionnaire process may be completed by phone or mail.

Also known as: Surveys

Close Relatives of Registered MDACC MEN Patients; Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

MEN1 and MEN2 patients at M.D. Anderson Cancer Center and their relatives

You may qualify if:

• Registered MDACC patients diagnosed with MEN1 or MEN2.
• Close relatives of registered MDACC MEN patients.

You may not qualify if:

• \. Individuals who are either non-MDACC registered patients or do not have a close relative who is an MEN patient registered at MDACC.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center

MeSH Terms

Conditions

Multiple Endocrine Neoplasia

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Neoplasms, Multiple Primary; Neoplastic Syndromes, Hereditary; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Nancy D. Perrier, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 7, 2017
• First Posted: February 9, 2017
• Study Start: September 5, 2001
• Primary Completion (Estimated): September 1, 2026
• Study Completion (Estimated): September 1, 2026
• Last Updated: April 16, 2026

Record last verified: 2026-04

Locations

US (1)